Suppr超能文献

重度抑郁症患者炎症细胞因子和微小RNA的横断面特质与状态生物标志物分析

A Cross-Sectional Trait Versus State Biomarker Analysis of Inflammatory Cytokines and miRNAs in Patients with Major Depressive Disorder.

作者信息

Rockson Christopher, Girish Chandrashekaran, Natarajan Harivenkatesh, Menon Vikas

机构信息

Dept. of Pharmacology, Jawaharlal Institute of Postgraduate Medical Education and Research (JIPMER), Puducherry, India.

*The first author made an oral presentation "The cytokine levels and miRNA expression in patients with major depressive disorder" on March 01, 2024, on the JIPMER Research Day 2024.

出版信息

Indian J Psychol Med. 2025 Jan;47(1):57-64. doi: 10.1177/02537176241279110. Epub 2024 Sep 23.

Abstract

BACKGROUND

Inflammatory cytokines are associated with the pathophysiology of major depressive disorder (MDD). Nevertheless, whether they are trait or state biomarkers remains unclear. We aimed to assess and compare selected cytokines, miRNAs, and oxidative stress biomarker levels between patients with MDD, first-degree relatives (FDRs), and unrelated healthy controls (UHCs).

METHODS

Using a cross-sectional design, we recruited patients with MDD, their FDRs and age, gender, body mass index-matched UHCs. Serum levels of IL-6, IL-1β, TNF-α, hs-CRP, and IL-10 were evaluated using the Enzyme-Linked Immunosorbent Assay (ELISA) method. We quantified the gene expressions of plasma miR-16, miR-132, and miR-1202 using Quantitative Real Time-Polymerase Chain Reaction (qRT-PCR). We estimated the total oxidant status and total antioxidant status levels in the serum by ELISA. We used sequential multiple linear regression analysis to find the association between MDD vs. UHCs (model 1), FDRs vs. UHCs (model 2), and MDD vs. FDRs (model 3) after adjusting for age, gender, and BMI as covariates.

RESULTS

The study involved 50 patients with MDD (mean age = 34.7 ± 10.1 years), 31 FDRs (mean age = 32.7 ± 12.2 years), and 50 UHCs (mean age = 34.1 ± 10.3 years). Patients with MDD had higher levels IL-6 (β = 6.04; 95% CI; 1.60 to 10.49; p = 0.008) and downregulated miR-1202 (β = -0.38; 95% CI: -0.70 to -0.06; p = 0.02) compared to FDRs with statistically significant differences.

CONCLUSION

The higher levels of serum IL-6 and downregulated plasma miR-1202 expression in patients with MDD compared to FDRs may be a state biomarkers in MDD. However, an adequately powered study can answer these questions with certainty.

摘要

背景

炎性细胞因子与重度抑郁症(MDD)的病理生理学相关。然而,它们是特质生物标志物还是状态生物标志物仍不清楚。我们旨在评估和比较MDD患者、一级亲属(FDRs)和无关健康对照(UHCs)之间选定的细胞因子、微小RNA(miRNAs)和氧化应激生物标志物水平。

方法

采用横断面设计,我们招募了MDD患者、他们的FDRs以及年龄、性别、体重指数匹配的UHCs。使用酶联免疫吸附测定(ELISA)方法评估血清白细胞介素-6(IL-6)、白细胞介素-1β(IL-1β)、肿瘤坏死因子-α(TNF-α)、高敏C反应蛋白(hs-CRP)和白细胞介素-10(IL-10)的水平。我们使用定量实时聚合酶链反应(qRT-PCR)对血浆微小RNA-16(miR-16)、微小RNA-132(miR-132)和微小RNA-1202(miR-1202)的基因表达进行定量。我们通过ELISA估计血清中的总氧化剂状态和总抗氧化剂状态水平。在将年龄、性别和体重指数作为协变量进行调整后,我们使用逐步多元线性回归分析来发现MDD与UHCs之间(模型1)、FDRs与UHCs之间(模型2)以及MDD与FDRs之间(模型3)的关联。

结果

该研究纳入了50例MDD患者(平均年龄=34.7±10.1岁)、31例FDRs(平均年龄=32.7±12.2岁)和50例UHCs(平均年龄=34.1±10.3岁)。与FDRs相比,MDD患者的IL-6水平更高(β=6.04;95%置信区间[CI]:1.60至10.49;p=0.008),miR-1202下调(β=-0.38;95%CI:-0.70至-0.06;p=0.02),差异具有统计学意义。

结论

与FDRs相比,MDD患者血清IL-6水平升高和血浆miR-1202表达下调可能是MDD的状态生物标志物。然而,一项样本量充足的研究可以确定地回答这些问题。

相似文献

1
A Cross-Sectional Trait Versus State Biomarker Analysis of Inflammatory Cytokines and miRNAs in Patients with Major Depressive Disorder.
Indian J Psychol Med. 2025 Jan;47(1):57-64. doi: 10.1177/02537176241279110. Epub 2024 Sep 23.
6
Predictive Value of Inflammatory Biomarkers in Assessing Major Depression in Adults.
Biomedicines. 2024 Oct 31;12(11):2501. doi: 10.3390/biomedicines12112501.
7
Serum cytokines-based biomarkers in the diagnosis and monitoring of therapeutic response in patients with major depressive disorder.
Int Immunopharmacol. 2023 May;118:110108. doi: 10.1016/j.intimp.2023.110108. Epub 2023 Mar 31.
8
Abnormal Distribution and Function of Circulating Monocytes and Enhanced Bacterial Translocation in Major Depressive Disorder.
Front Psychiatry. 2019 Nov 15;10:812. doi: 10.3389/fpsyt.2019.00812. eCollection 2019.
10
Comparison of serum cytokines levels in normal-weight and overweight patients with first-episode drug-naïve major depressive disorder.
Front Endocrinol (Lausanne). 2022 Oct 27;13:1048337. doi: 10.3389/fendo.2022.1048337. eCollection 2022.

本文引用的文献

2
Major depressive disorder: hypothesis, mechanism, prevention and treatment.
Signal Transduct Target Ther. 2024 Feb 9;9(1):30. doi: 10.1038/s41392-024-01738-y.
4
The role of microRNAs in depression.
Front Pharmacol. 2023 Mar 29;14:1129186. doi: 10.3389/fphar.2023.1129186. eCollection 2023.
5
How does IL-6 change after combined treatment in MDD patients? A systematic review.
Brain Behav Immun Health. 2022 Dec 24;27:100579. doi: 10.1016/j.bbih.2022.100579. eCollection 2023 Feb.
7
MicroRNAs as Critical Biomarkers of Major Depressive Disorder: A Comprehensive Perspective.
Biomedicines. 2021 Nov 10;9(11):1659. doi: 10.3390/biomedicines9111659.
8
Emerging role of microRNAs in major depressive disorder and its implication on diagnosis and therapeutic response.
J Affect Disord. 2021 May 1;286:80-86. doi: 10.1016/j.jad.2021.02.063. Epub 2021 Mar 4.
9
On inflammatory hypothesis of depression: what is the role of IL-6 in the middle of the chaos?
J Neuroinflammation. 2021 Feb 16;18(1):45. doi: 10.1186/s12974-021-02100-7.
10
Association study between immune-related miRNAs and mixed connective tissue disease.
Arthritis Res Ther. 2021 Jan 11;23(1):19. doi: 10.1186/s13075-020-02403-9.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验